Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 236 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2019-06-05 | 2019-11-11 | 85604 |
APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2019-06-05 | 2019-11-11 | 85607 |
OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2019-06-05 | 2019-09-23 | 85622 |
APO-ALENDRONATE | 70MG | TABLET | Resolved | 2019-06-12 | 2019-07-12 | 86271 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2019-06-12 | 2019-08-30 | 86327 |
APO-AMOXI CLAV | 875MG 125MG | TABLET | Resolved | 2019-06-19 | 2019-09-23 | 87057 |
APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2019-06-19 | 2019-11-11 | 87060 |
APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-06-26 | 2020-01-20 | 87517 |
APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2019-07-03 | 2019-08-12 | 88323 |
APO-BACLOFEN | 10MG | TABLET | Resolved | 2019-07-03 | 2019-07-29 | 88328 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2019-07-03 | 2020-02-03 | 88368 |
APO-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2019-07-03 | 2020-01-06 | 88371 |
APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2019-07-12 | 2019-08-31 | 89152 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-07-12 | 2019-08-17 | 89158 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-07-12 | 2019-11-25 | 89167 |
APO-RILUZOLE | 50MG | TABLET | Resolved | 2019-07-12 | 2019-09-16 | 89170 |
APO-CAPTO TAB 25MG | 25MG | TABLET | Resolved | 2019-07-17 | 2019-09-16 | 89510 |
APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2019-07-17 | 2019-12-19 | 89513 |
APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2019-07-17 | 2019-12-19 | 89545 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2019-07-17 | 2019-12-19 | 89548 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |